Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 2
2020 2
2021 2
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Impact of micronised progesterone and medroxyprogesterone acetate in combination with transdermal oestradiol on cardiovascular markers in women diagnosed with premature ovarian insufficiency or an early menopause: a randomised pilot trial.
Mittal M, McEniery C, Supramaniam PR, Cardozo L, Savvas M, Panay N, Hamoda H. Mittal M, et al. Among authors: supramaniam pr. Maturitas. 2022 Jul;161:18-26. doi: 10.1016/j.maturitas.2022.01.012. Epub 2022 Feb 2. Maturitas. 2022. PMID: 35688490 Clinical Trial.
The effect of micronized progesterone and medroxyprogesterone acetate in combination with transdermal estradiol on hemostatic biomarkers in postmenopausal women diagnosed with POI and early menopause: a randomized trial.
Mittal M, Chitongo P, Supramaniam PR, Cardozo L, Savvas M, Panay N, Arya R, Hamoda H. Mittal M, et al. Among authors: supramaniam pr. Menopause. 2022 May 1;29(5):580-589. doi: 10.1097/GME.0000000000001944. Menopause. 2022. PMID: 35486948 Clinical Trial.
A direct comparison of women's perceptions and acceptability of micronised progesterone and medroxyprogesterone acetate in combination with transdermal oestradiol in the management of young postmenopausal women, under 45 years of age.
Mittal M, Panay N, Supramaniam PR, Savvas M, Cardozo L, Hamoda H. Mittal M, et al. Among authors: supramaniam pr. Post Reprod Health. 2020 Dec;26(4):210-219. doi: 10.1177/2053369120960960. Epub 2020 Oct 12. Post Reprod Health. 2020. PMID: 33045913 Clinical Trial.